DK1291350T3 - 6-0-substituerede ketolider med antibakteriel aktivitet - Google Patents

6-0-substituerede ketolider med antibakteriel aktivitet

Info

Publication number
DK1291350T3
DK1291350T3 DK02024557T DK02024557T DK1291350T3 DK 1291350 T3 DK1291350 T3 DK 1291350T3 DK 02024557 T DK02024557 T DK 02024557T DK 02024557 T DK02024557 T DK 02024557T DK 1291350 T3 DK1291350 T3 DK 1291350T3
Authority
DK
Denmark
Prior art keywords
alkyl
substituted
heteroaryl
aryl
optionally substituted
Prior art date
Application number
DK02024557T
Other languages
Danish (da)
English (en)
Inventor
Richard F Clark
Jacob J Plattner
Daniel T Chu
Yat Sun Or
Zhenkun Ma
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27107953&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1291350(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/888,350 external-priority patent/US5866549A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1291350T3 publication Critical patent/DK1291350T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cephalosporin Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK02024557T 1996-09-04 1997-09-02 6-0-substituerede ketolider med antibakteriel aktivitet DK1291350T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70777696A 1996-09-04 1996-09-04
US08/888,350 US5866549A (en) 1996-09-04 1997-07-03 6-O-substituted ketolides having antibacterial activity
EP97939765A EP0929563B1 (en) 1996-09-04 1997-09-02 6-o-substituted ketolides having antibacterial activity

Publications (1)

Publication Number Publication Date
DK1291350T3 true DK1291350T3 (da) 2005-09-26

Family

ID=27107953

Family Applications (5)

Application Number Title Priority Date Filing Date
DK02024558T DK1291351T3 (da) 1996-09-04 1997-09-02 6-O-substituerede ketolider med antibakteriel aktivitet
DK02024559T DK1291352T3 (da) 1996-09-04 1997-09-02 6-O-substituerede ketolider med antibakteriel aktivitet
DK02024560T DK1291353T3 (da) 1996-09-04 1997-09-02 6-O-substituerede ketolider med antibakteriel aktivitet
DK97939765T DK0929563T3 (da) 1996-09-04 1997-09-02 6-O-substituerede ketolider med antibakteriel aktivitet
DK02024557T DK1291350T3 (da) 1996-09-04 1997-09-02 6-0-substituerede ketolider med antibakteriel aktivitet

Family Applications Before (4)

Application Number Title Priority Date Filing Date
DK02024558T DK1291351T3 (da) 1996-09-04 1997-09-02 6-O-substituerede ketolider med antibakteriel aktivitet
DK02024559T DK1291352T3 (da) 1996-09-04 1997-09-02 6-O-substituerede ketolider med antibakteriel aktivitet
DK02024560T DK1291353T3 (da) 1996-09-04 1997-09-02 6-O-substituerede ketolider med antibakteriel aktivitet
DK97939765T DK0929563T3 (da) 1996-09-04 1997-09-02 6-O-substituerede ketolider med antibakteriel aktivitet

Country Status (28)

Country Link
US (4) US6075133A (ja)
EP (5) EP1291353B1 (ja)
JP (1) JP4597274B2 (ja)
KR (5) KR20050044816A (ja)
CN (4) CN100460415C (ja)
AT (5) ATE299508T1 (ja)
BG (1) BG63547B1 (ja)
BR (1) BR9711661A (ja)
CA (1) CA2263972C (ja)
CZ (1) CZ300106B6 (ja)
DE (5) DE69733439T2 (ja)
DK (5) DK1291351T3 (ja)
ES (5) ES2242811T3 (ja)
HK (1) HK1021537A1 (ja)
HR (5) HRP970473B1 (ja)
HU (1) HU230166B1 (ja)
ID (1) ID19406A (ja)
IL (1) IL128681A0 (ja)
NO (1) NO314230B1 (ja)
NZ (1) NZ334274A (ja)
PL (1) PL188173B1 (ja)
PT (5) PT1291350E (ja)
RO (1) RO121473B1 (ja)
RU (1) RU2192427C2 (ja)
SI (1) SI20023B (ja)
SK (5) SK285533B6 (ja)
TR (1) TR199901127T2 (ja)
WO (1) WO1998009978A1 (ja)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495348B1 (en) 1993-10-07 2002-12-17 Regents Of The University Of Minnesota Mitomycin biosynthetic gene cluster
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
ES2199524T3 (es) 1998-04-24 2004-02-16 Pfizer Products Inc. Derivados 9a,11b-deshidro de 9-oxima-3-ceto-6-o-metileritromicina.
US6265202B1 (en) 1998-06-26 2001-07-24 Regents Of The University Of Minnesota DNA encoding methymycin and pikromycin
JP4573925B2 (ja) 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2792637B1 (fr) * 1999-04-26 2001-06-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2785612A1 (fr) 1998-11-10 2000-05-12 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CA2349338C (en) 1998-11-03 2005-12-06 Pfizer Products Inc. Novel macrolide antibiotics
CZ20013223A3 (cs) * 1999-03-15 2002-01-16 Abbott Laboratories 6-0-Substituované makrolidy mající antibakteriální aktivitu
NZ515027A (en) * 1999-04-16 2004-01-30 Kosan Biosciences Inc Erythromycin derivatives as antibiotics
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6420535B1 (en) * 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
ATE250076T1 (de) * 1999-06-07 2003-10-15 Abbott Lab 6-o-carbamat ketolide derivate
US6417366B2 (en) * 1999-06-24 2002-07-09 Abbott Laboratories Preparation of quinoline-substituted carbonate and carbamate derivatives
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
EP1101769A3 (en) 1999-11-18 2001-10-24 Pfizer Products Inc. Nitrogen containing erythromycin derivatives
US6472372B1 (en) 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
JP4509553B2 (ja) * 2001-07-03 2010-07-21 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 抗菌活性を有するｃ１２修飾エリスロマイシンマクロライドおよびケトライド
WO2003024986A1 (en) 2001-09-17 2003-03-27 Ortho-Mcneil Pharmaceutical, Inc. 6-o-carbamate-11,12-lacto-ketolide antimicrobials
US6673774B2 (en) * 2001-12-03 2004-01-06 Enanta Pharmaceuticals, Inc. 11-O-substituted macrolides and their descladinose derivatives
BR0214748A (pt) 2001-12-05 2004-11-23 Ortho Mcneil Pharm Inc Derivados 6-oacil-cetolidas de eritromicina, úteis como antibacterianos
WO2003068790A2 (en) * 2002-02-13 2003-08-21 Abbott Laboratories Macrolide antibacterial compounds
US20030162729A1 (en) * 2002-02-13 2003-08-28 Zhenkun Ma Macrolides with activity against methicillin-resistant staphylococcus aureus
US6831068B2 (en) * 2002-02-13 2004-12-14 Abbott Laboratories Macrolide antibacterial compounds
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US6995143B2 (en) 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6841664B2 (en) * 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US6825172B2 (en) 2002-05-31 2004-11-30 Janssen Pharmaceutica, Nv 3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents
WO2004078771A1 (ja) * 2003-03-07 2004-09-16 Taisho Pharmaceutical Co., Ltd. ２－フルオロ－６－ｏ－置換ケトライド誘導体
WO2004080391A2 (en) 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
EP1618120A2 (en) * 2003-04-25 2006-01-25 Chiron Corporation Novel ketolide derivatives
US20040254126A1 (en) * 2003-06-05 2004-12-16 Yao-Ling Qiu 11-12 Bicyclic erythromycin derivatives
US6790835B1 (en) * 2003-06-05 2004-09-14 Enanta Pharmaceuticals, Inc. Bicyclic macrolide derivatives
EP1670808A1 (en) * 2003-09-12 2006-06-21 Chiron Corporation Antimicrobial derivatives
GB0327720D0 (en) * 2003-11-28 2003-12-31 Biotica Tech Ltd Erythromycins and process for their preparation
US7414030B2 (en) * 2004-01-07 2008-08-19 Enanta Pharmaceuticals, Inc. 6-11 Bicyclic erythromycin derivatives
WO2005070113A2 (en) * 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
FR2874922A1 (fr) * 2004-07-30 2006-03-10 Palumed Sa Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
JP2008508243A (ja) * 2004-07-30 2008-03-21 パルメド・ソシエテ・アノニム アミノキノリンをｑとし、抗生物質残基をａとする混成分子ｑａ、その合成及び抗菌剤としての使用
US7312201B2 (en) * 2004-12-13 2007-12-25 Enanta Pharmaceuticals, Inc. Tetracyclic bicyclolides
EP1836211B1 (en) 2004-12-21 2010-03-03 Pfizer Products Inc. Macrolides
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060252710A1 (en) * 2005-05-04 2006-11-09 Guoqiang Wang 6-11 Bridged oxime erythromycin derivatives
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
EP1985620A4 (en) 2006-02-07 2012-08-15 Taisho Pharmaceutical Co Ltd COMPOUND 10a-AZALIDE
EP2056844A4 (en) 2006-08-24 2010-11-24 Wockhardt Research Center NEW MACROLIDS AND KETOLIDS WITH ANTIMICROBIAL EFFECT
EP2177526A4 (en) 2007-08-06 2012-08-22 Taisho Pharmaceutical Co Ltd 10A-AZALIDE COMPOUND CROSS-LINKED IN POSITION 10A AND POSITION 12
NZ584159A (en) * 2007-09-17 2012-08-31 Enanta Pharm Inc 6,11-bridged biaryl macrolides
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
CA2703475A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
EP2287173A4 (en) 2008-05-15 2013-06-19 Taisho Pharmaceutical Co Ltd 10A-AZALIDE COMPOUND HAVING 4 CHAIN CYCLE STRUCTURE
EP2358379B1 (en) * 2008-10-24 2015-12-16 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
BRPI1011959A2 (pt) 2009-05-27 2016-04-26 Wockhardt Research Center compostos de cetolídeo tendo atividade antimicrobiana.
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
PL2550286T3 (pl) 2010-03-22 2016-07-29 Cempra Pharmaceuticals Inc Krystaliczne postaci makrolidu i ich zastosowanie
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
US8796474B1 (en) 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
PL2673285T3 (pl) 2010-12-09 2017-12-29 Wockhardt Limited Związki ketolidowe
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
KR101567658B1 (ko) 2011-03-01 2015-11-09 욱크하르트 리미티드 케톨리드 중간체의 제조 방법
KR101795838B1 (ko) 2011-03-22 2017-11-08 욱크하르트 리미티드 케톨리드 화합물의 제조 방법
CN102766181A (zh) * 2011-05-06 2012-11-07 上海医药工业研究院 6-o-取代的红霉素衍生物的制备方法
CN102766089A (zh) * 2011-05-06 2012-11-07 上海医药工业研究院 3-(3-喹啉基)-2-丙烯-1-卤代物及其制备方法
CN104470527B (zh) 2012-03-27 2019-05-28 森普拉制药公司 用于施用大环内酯抗生素的肠胃外制剂
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 Ｃ−４”位置換マクロライド誘導体を含有する医薬
GB201217310D0 (en) 2012-09-27 2012-11-14 C10 Pharma As Compounds
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
AR102810A1 (es) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
CN110234323A (zh) * 2016-10-04 2019-09-13 Ti生物制药有限公司 具有抗菌活性的酮内酯
EP3589327A4 (en) * 2017-03-03 2022-04-06 Synovo GmbH NOVEL ANTI-INFECTION AND ANTI-INFLAMMATORY COMPOUNDS
CN109942653B (zh) * 2019-02-27 2021-06-25 北京理工大学 一种红霉素衍生物及其制备方法
JP2023504262A (ja) * 2019-12-02 2023-02-02 アリクァンタムアールエクス，インコーポレイテッド 疾患の治療のためのセスロマイシンの塩及び多形体 セスロマイシンの塩及び多形体
CN113817008B (zh) * 2021-07-15 2023-05-23 湖州师范学院 新型琥珀酰基十六元大环内酯的制备方法及用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
CA2094060A1 (en) * 1990-10-15 1992-04-16 Toshifumi Asaka 2'-position modified compound of erythromycin or its derivative
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
ATE157368T1 (de) * 1990-11-28 1997-09-15 Taisho Pharmaceutical Co Ltd 6-0-methylerythromycin a-derivat
WO1993013663A1 (en) * 1992-01-17 1993-07-22 Abbott Laboratories Method of directing biosynthesis of specific polyketides
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
CA2093303C (en) * 1992-04-09 1998-11-24 Abraham Araya Aluminosilicates
KR100244729B1 (ko) * 1992-04-22 2000-02-15 우에하라 아끼라 5-0-데소사미닐에리쓰로노라이드a유도체
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2713226B1 (fr) * 1993-12-03 1996-01-05 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2732684B1 (fr) * 1995-04-06 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2738571B1 (fr) * 1995-09-11 1997-10-17 Roussel Uclaf Nouveaux derives de la 5-0-desosaminyl 6-0-methyl- erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
AU7447096A (en) * 1995-11-08 1997-05-29 Abbott Laboratories Tricyclic erythromycin derivatives
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
WO1998018808A1 (en) * 1996-10-31 1998-05-07 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6171807B1 (en) * 1996-11-13 2001-01-09 Associates Of Cape Cod, Inc. Detection and quantitation of endotoxin by fluorescence polarization

Also Published As

Publication number Publication date
WO1998009978A1 (en) 1998-03-12
BR9711661A (pt) 1999-08-24
ES2242983T3 (es) 2005-11-16
ES2242811T3 (es) 2005-11-16
SK28699A3 (en) 2000-03-13
HK1021537A1 (en) 2000-06-16
PT1291351E (pt) 2005-11-30
PT1291353E (pt) 2005-10-31
ATE296307T1 (de) 2005-06-15
CA2263972A1 (en) 1998-03-12
CN1237183A (zh) 1999-12-01
HU230166B1 (hu) 2015-09-28
RU2192427C2 (ru) 2002-11-10
US6028181A (en) 2000-02-22
US6147197A (en) 2000-11-14
DE69733422D1 (de) 2005-07-07
NO314230B1 (no) 2003-02-17
USRE39591E1 (en) 2007-04-24
DE69733370D1 (de) 2005-06-30
DE69733369D1 (de) 2005-06-30
DE69733369T2 (de) 2006-01-26
PT929563E (pt) 2005-10-31
RO121473B1 (ro) 2007-06-29
KR100610043B1 (ko) 2006-08-08
PT1291352E (pt) 2005-09-30
DE69733723T2 (de) 2006-04-20
CN1680418A (zh) 2005-10-12
EP1291350B1 (en) 2005-05-25
CN1680419A (zh) 2005-10-12
DE69733439T2 (de) 2006-05-04
AU4178097A (en) 1998-03-26
TR199901127T2 (xx) 1999-07-21
EP1291353A1 (en) 2003-03-12
PL188173B1 (pl) 2004-12-31
CN1273475C (zh) 2006-09-06
KR20050044815A (ko) 2005-05-12
HRP20060277A2 (en) 2007-10-31
BG103292A (en) 1999-12-30
ES2244716T3 (es) 2005-12-16
SK285536B6 (sk) 2007-03-01
JP4597274B2 (ja) 2010-12-15
KR100576988B1 (ko) 2006-05-10
EP1291351B1 (en) 2005-07-13
EP1291351A1 (en) 2003-03-12
DE69733723D1 (de) 2005-08-18
EP1291352B1 (en) 2005-05-25
KR20050043994A (ko) 2005-05-11
CZ68599A3 (cs) 1999-08-11
EP1291353B1 (en) 2005-06-01
SK285533B6 (sk) 2007-03-01
HRP20060277B1 (hr) 2014-04-11
EP1291352A1 (en) 2003-03-12
JP2001500855A (ja) 2001-01-23
PT1291350E (pt) 2005-09-30
HRP20060278A2 (en) 2007-10-31
US6075133A (en) 2000-06-13
EP0929563A1 (en) 1999-07-21
ATE296308T1 (de) 2005-06-15
SI20023A (sl) 2000-02-29
DE69733422T2 (de) 2006-05-04
KR20050044816A (ko) 2005-05-12
HRP20060276B1 (hr) 2014-04-25
HRP970473A2 (en) 1998-08-31
HRP20060275A2 (en) 2007-10-31
EP1291350A1 (en) 2003-03-12
SI20023B (en) 2001-02-28
CZ300106B6 (cs) 2009-02-11
DE69733439D1 (de) 2005-07-07
SK286181B6 (sk) 2008-04-07
NO991022D0 (no) 1999-03-02
KR100523679B1 (ko) 2005-10-26
NO991022L (no) 1999-05-03
NZ334274A (en) 2001-02-23
EP0929563B1 (en) 2005-06-01
ATE296832T1 (de) 2005-06-15
ES2242813T3 (es) 2005-11-16
DK1291353T3 (da) 2005-10-03
CN1680420A (zh) 2005-10-12
KR20050043993A (ko) 2005-05-11
KR20000068435A (ko) 2000-11-25
BG63547B1 (bg) 2002-04-30
SK285535B6 (sk) 2007-03-01
IL128681A0 (en) 2000-01-31
HRP970473B1 (en) 2007-02-28
CN100460415C (zh) 2009-02-11
DE69733370T2 (de) 2006-02-02
ES2242812T3 (es) 2005-11-16
CA2263972C (en) 2008-01-29
PL332009A1 (en) 1999-08-16
HRP20060275B1 (hr) 2014-04-11
SK285534B6 (sk) 2007-03-01
ATE296831T1 (de) 2005-06-15
HUP9902869A2 (hu) 2000-02-28
ID19406A (id) 1998-07-09
DK0929563T3 (da) 2005-10-03
CN100441591C (zh) 2008-12-10
KR100568455B1 (ko) 2006-04-07
ATE299508T1 (de) 2005-07-15
HRP20060276A2 (en) 2007-10-31
HUP9902869A3 (en) 2001-04-28
DK1291352T3 (da) 2005-09-19
AU729348B2 (en) 2001-02-01
HRP20060278B1 (hr) 2014-04-11
DK1291351T3 (da) 2005-10-24

Similar Documents

Publication Publication Date Title
DK1291350T3 (da) 6-0-substituerede ketolider med antibakteriel aktivitet
CA2096969A1 (en) 6-0-methylerythromycin a derivatives
EP0107201A3 (en) Phenyl-substituted tricyclic antibacterial agents
PL357379A1 (en) Use of chemotherapeutic agents for topical treatment
IL79269A0 (en) 5-imidazolecarboxylic acid derivatives,their preparation and their use as herbicides
ES2010071A6 (es) Procedimiento para preparar derivados de isoquinolina.
ES8801288A1 (es) Un procedimiento para la preparacion de derivados de cefalosporina
ES8505691A1 (es) Un procedimiento para preparar derivados de cefem
ES8403919A1 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
EP0677522A4 (en) 8-METHOXYQUINOLONECARBOXYLIC ACID DERIVATIVE.
NZ334317A (en) beta-lactam compounds as antibacterial agents effective against methicillin-resistant and coagulase-negative Staphylococci and process for preparing the same
HUP9902893A2 (hu) 6-O-Szubsztituált eritromicinszármazékok és eljárás előállításukra
TW349950B (en) Substituted tetracyclic azepine derivatives
IE43346L (en) Cephalosporin derivatives.
ES482550A1 (es) Un procedimiento para la produccion de derivados de cefalos-porina.
EP0926139A4 (en) CHINOLINE SULFIDE DERIVATIVES
IE892683L (en) Amino-substituted bridged azabicyclic quinolone carboxylic¹acids and esters
ES8707188A1 (es) Procedimiento para la preparacion de compuestos de actividad antibacteriana
ES8702420A1 (es) Procedimiento para la obtencion de compuestos de aminoal- quilpenem
ZA972324B (en) Novel herbicides.
EP0652220A4 (en) CEPHALOSPORINE DERIVATIVES.